Short interest in Gain Therapeutics Inc (NASDAQ:GANX) decreased during the last reporting period, falling from 718.74K to 580.55K. This put 2.29% of the company's publicly available shares short.

Short interest for Gain Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Gain Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 212.01K shares traded per day, it would take 2.74 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.